Primary prevention of cardiovascular disease end points using beta-blockers (vol 277, pg 1759, 1997)

被引：0
作者：
Michalewicz, L
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1997年 / 278卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：900 / 900
页数：1
相关论文
共 50 条
[21]   US Preventive Services Task Force. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force (vol 316, pg 1997, 2016) [J].
Bibbins-Domingo, K. ;
Grossman, D. C. ;
Curry, S. J. ;
Davidson, K. W. ;
Epling, J. W., Jr. ;
García, F. A. R. ;
Gillman, M. W. ;
Kemper, A. R. ;
Krist, A. H. ;
Kurth, A. E. ;
Landefeld, C. S. ;
LeFevre, M. L. ;
Mangione, C. M. ;
Phillips, W. R. ;
Owens, D. K. ;
Phipps, M. G. ;
Pignone, M. P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (07) :669-669
[22]   Telehealth interventions for primary prevention of cardiovascular disease: A systematic review and meta-analysis (vol 64, pg 88, 2014) [J].
Merriel, Samuel William David ;
Andrews, Verity ;
Salisbury, Christopher .
PREVENTIVE MEDICINE, 2014, 67 :343-343
[23]   Persistence With Statins in Primary Prevention of Cardiovascular Disease: Findings From a Cohort of Spanish Workers (vol 71, pg 26, 2018) [J].
Malo .
REVISTA ESPANOLA DE CARDIOLOGIA, 2020, 73 (05) :434-434
[24]   LONG-TERM MORTALITY AFTER PRIMARY PREVENTION FOR CARDIOVASCULAR-DISEASE (JAMA, VOL 267, PG 2183, 1992) [J].
BASSLER, TJ ;
HOLME, I ;
NEWMAN, TB ;
BROWNER, WS ;
HULLEY, SB ;
MODEST, G ;
MOGADAM, M ;
STRANDBERG, TE ;
SALOMAA, VV ;
VANHANEN, H ;
SARNA, S ;
MIETTINEN, TA ;
NAUKKARINEN, V ;
PAUL, O ;
HENNEKENS, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (05) :591-591
[25]   Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease (vol 15, pg 420, 2004) [J].
Wrone, EM ;
Hornberger, JM ;
Zehnder, JL ;
McCann, LM ;
Coplon, NS ;
Fortmann, SP .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (05) :CP4-CP4
[26]   Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study (vol 40, pg 1587, 2018) [J].
Amadi, Casmir E. ;
Lawal, Folasade O. ;
Mbakwem, Amam C. ;
Ajuluchukwu, Jayne N. ;
Oke, David A. .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) :293-293
[27]   Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin (vol 107, pg 1796, 2011) [J].
Bartolucci .
AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (04) :615-615
[28]   Quantifying the health benefits of chronic disease prevention: a fresh approach using cardiovascular disease as an example (vol 29, pg 605, 2014) [J].
Wald, Nicholas J. ;
Morris, Joan K. .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2015, 30 (06) :521-523
[29]   Estimating the benefits of modifying risk factors of cardiovascular disease - A comparison of primary vs secondary prevention (vol 158, pg 655, 1998) [J].
Grover, SA ;
Paquet, S ;
Levinton, C ;
Coupal, L ;
Zowall, H .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (11) :1228-1228
[30]   RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet (Retracted article. See vol. 378, pg. 2441, 2018) [J].
Estruch, Ramon ;
Ros, Emilio ;
Salas-Salvado, Jordi ;
Covas, Maria-Isabel ;
Corella, Dolores ;
Aros, Fernando ;
Gomez-Gracia, Enrique ;
Ruiz-Gutierrez, Valentina ;
Fiol, Miquel ;
Lapetra, Jose ;
Maria Lamuela-Raventos, Rosa ;
Serra-Majem, Lluis ;
Pinto, Xavier ;
Basora, Josep ;
Angel Munoz, Miguel ;
Sorli, Jose V. ;
Alfredo Martinez, Jose ;
Angel Martinez-Gonzalez, Miguel .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (14) :1279-1290
12345